Dutasteride Mesotherapy Guide

Dutasteride mesotherapy delivers dutasteride — a potent dual 5α-reductase inhibitor — directly into the scalp dermis via micro-injections. This targets DHT suppression precisely at the hair follicle level, with clinical data showing efficacy superior to topical finasteride and with a more favorable systemic side effect profile than oral dutasteride.

Dutasteride mesotherapy (also called alopecia intralesional dutasteride therapy) involves injecting diluted dutasteride solution (typically 0.5-1mg per session) intradermally across the scalp using a 4mm 30G mesotherapy needle or automated mesotherapy gun. Dutasteride inhibits both isoforms of 5α-reductase (Type I and Type II), blocking conversion of testosterone to DHT with greater potency and completeness than finasteride (which only inhibits Type II). Intradermal delivery concentrates the drug in scalp tissue where it can act on follicle cells — achieving local DHT suppression without the full systemic DHT reduction of oral dutasteride.

Dutasteride mesotherapy protocol varies by clinic — most use monthly sessions with this dose framework:

Never rely on memory for high-leverage metabolic or hormonal interventions. Shotlee ensures your entire protocol history is immutably recorded, highly visible, and perfectly charted to prevent accidental overlaps or dosing errors.

Safety Through Data Logging: Never rely on memory for high-leverage metabolic or hormonal interventions. Shotlee ensures your entire protocol history is immutably recorded, highly visible, and perfectly charted to prevent accidental overlaps or dosing errors.